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Abstract
Objectives: Long-term opioid use after hip fracture sur-
gery has been demonstrated in previously opioid-naïve
elderly patients. It is unknown if the opioid type redeemed
after hip surgery is associated with long-term opioid use.
The aim of this study was to examine the association be-
tween the opioid type redeemed within the first three
months after hip fracture surgery and opioid use 3–
12 months after the surgery.
Methods: A nationwide population-based cohort study
was conducted using data from Danish health registries
(2005–2015). Previously opioid-naïve patients registered in
the Danish Multidisciplinary Hip Fracture Registry,
aged ≥65 years, who redeemed ≥1 opioid prescription
within three months after the surgery, were included.
Long-term opioid use was defined as ≥1 redeemed pre-
scription within each of three three-month periods within
the year after hip fracture surgery. The proportion with
long-term opioid use after surgery, conditioned on nine-
month survival, was calculated according to opioid types
within three months after surgery. Adjusted odds ratios
(aOR) for different opioid types were computed by logistic
regression analyses with 95% confidence intervals (CI)
using morphine as reference. Subgroup analyses were
performed according to age, comorbidity and calendar
time before and after 2010.
Results: The study included 26,790 elderly, opioid-naïve
patients with opioid use within three months after hip frac-
ture surgery. Of these patients, 21% died within nine months
after the surgery.Among the 21,255patients aliveninemonths
after surgery, 15% became long-term opioid users. Certain
opioid types used within the first three months after surgery
were associated with long-term opioid use compared to
morphine (9%), including oxycodone (14%, aOR; 1.76, 95%
CI 1.52–2.03), fentanyl (29%, aOR; 4.37, 95% CI 3.12–6.12),
codeine (13%, aOR; 1.55, 95% CI 1.14–2.09), tramadol (13%,
aOR; 1.56, 95%CI 1.35–1.80), buprenorphine (33%, aOR; 5.37,
95%CI 4.14–6.94), and>1 opioid type (27%,aOR; 3.83, 95%CI
3.31–4.44). The proportion of long-term opioid users
decreased from 18% before 2010 to 13% after 2010.
Conclusions: The findings suggest that use of certain opioid
types after hip fracture surgery is more associated with long-
term opioid use than morphine and the proportion initiating
long-term opioid use decreased after 2010. The findings
suggest that some elderly, opioid-naïve patients appear to be
presented with untreated pain conditions when seen in the
hospital for a hip fracture surgery. Decisions regarding the
opioid type prescribed after hospitalization for hip fracture
surgery may be linked to different indication for pain treat-
ment, emphasizing the likelihood of careful and conscien-
tious opioid prescribing behavior.
Keywords: hip fracture surgery; opioid; opioid cessation.
Introduction
Hip fracture surgery is frequent in the elderly population
with an incidenced rate of up to four cases per 1,000
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person-years in Denmark [1]. Despite age-standardized
incidence rates seem decreasing in most countries; the
decrease in rates is exceeded by an increase in absolute
numbers due to the aging of the populations [2]. Hip frac-
ture patients are typically fragile and often present with
comorbidity and polypharmacy making them more
vulnerable to drug interactions and adverse events [3].
Lindestrand et al. (2015) found that 95%of 416 admitted hip
fracture patients received opioids for acute pain manage-
ment during the hospital admission and 3% of 416
admitted hip fracture patients were opioid users after six
months [4]. Another study has shown that 17% of previ-
ously opioid-naïve patients redeemed opioid prescriptions
within 9–12 months after hip fracture surgery, and 8% of
previously opioid-naïve patients continued redeeming
opioid prescriptions in all four quarters after the surgery
[5].
Opioid use both in Denmark and worldwide seems
closely linked to the level of pain and aging in the popu-
lation [6]. Poor assessment of pain in elderly patients and
concerns of polypharmacy, tolerance, physical depen-
dence, addiction and adverse effects results in underutili-
zation of opioids and poor pain management in elderly
patients [7]. Underutilized pain management may gener-
ally result in readmissions, delayed recovery, morbidity,
mortality, and possibly chronic pain [8]. Although evi-
dence supporting the choice of one specific opioid type
over another is lacking, recommendations exist regarding
considerations of specific patient factors [9]. There has
been a global shift in patterns of prescription opioid use,
specifically the types of opioid prescribed [10–12], but the
total number of opioid users in Denmark has stabilized
from 2011 to 2012 up to 2017 [10, 12]. A study acrossmultiple
pain etiologies, including surgery, determined that higher
doses, longer durations, slow-release formulations and
prescribing of tramadol at initiation were associated with
long-term opioid use [13]. However, the indication for
opioid initiation was chronic pain for the majority of the
patients [13]. The prevalence of self-reported chronic non-
malignant pain in Denmark affected almost 27% of the
adult population in 2010, and the tendency to treat with
opioids increased from 2005 to 2013 and was highest
among elderly women [14]. The present study hypothesize
that the prescribers behavior and choice of opioid types
after hip fracture surgery in elderly patients, is linked to the
need of opioid therapy the year after surgery for the indi-
vidual patients, and opioid prescribing behavior have
changed as the public focus on misuse, addiction, and
withdrawal has increased.
The aim of this Danish nationwide cohort study was to
examine the association between the type of opioid
redeemed within three months after surgery and long-term
opioid use 3–12 months after surgery in opioid-naïve
elderly hip fracture patients from 2005 until 2015.
Methods
Study design and settings
This population-based cohort study was conducted in Denmark
(source population aged ≥65∼1.07 million in 2015 [15]), using pro-
spectively collected data from a nationwide clinical quality database
[16] and administrative data from national health registries, which
cover all contacts to the health-care sector [17]. Universal healthcare
for all Danish citizens is tax-supported and free [18]. This study was
approved by the Danish Data Protection Agency (Central Denmark
Region record number: 1-16-02-467-15).
Data sources
The study populationwas identified from theDanishMultidisciplinary
Hip Fracture Database and linked to additional data from the Danish
National Patient Registry (DNPR), the Danish National Health Service
Prescription Database, and the Danish Civil Registration System. A
complete list of the included codes for registry diagnoses, procedures,
and drugs is available in the supplemental (Appendix E1).
The Danish Multidisciplinary Hip Fracture Registry is a nation-
wide clinical registry of population-based pre-, peri-, and post-
operative data on all patients aged 65 ormorewho underwent surgical
treatment (osteosynthesis or total/partial hip replacement) for a pri-
mary hip fracture (fracture of femoral neck, per-, or sub-trochanter
fracture) in Denmark since 2003 (Table E1.1) [16]. Between 2004 and
2010, the registry was based on an online independent registration
system, but since 2010, the registry uses data directly reported to
DNPR. A number of new diagnostic and treatment codes have been
created in DNPR in order to transform all data from the Danish
Multidisciplinary Hip Fracture Registry registration platform to DNPR.
The primary data source in the present study is the Danish Multidis-
ciplinary Hip Fracture Registry. Although majority of clinical data is
pooled fromDNPR, this is recommended by clinicians and The Danish
Clinical Quality Program, National Clinical Registries in order to
maintain and further improve the continuously registration of codes
specifically established for this database in the DNPR [16]. However,
not all data are available in this database e.g. data on comorbidity and
prescriptions. The ability to identify hip fracture patients using
administrative databases is high because hip fracture surgery is an
acute hospital-based procedure and because of reimbursement policy
for both diagnosis and surgery codes [19].
Additionally, theDNPRholds records on all inpatient admissions to
Danish somatic hospitals since 1977 and outpatient discharges and
emergency room visits since 1995. Diagnoses are coded according to the
International Classification of Diseases, Eight Revision (ICD-8) from 1977
to 1993 and according to International Classification of Diseases, 10th
Revision (ICD-10) thereafter [20]. All somatic diagnoses 10 years before
surgery (thus, until 1995) were identified based on ICD-10.
The Danish National Health Service Prescription Database holds
information on all prescription drugs distributed by Danish
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pharmacies after 2004, identified by the Anatomical Therapeutic
Chemical classification system codes (ATC codes) [21]. The Danish
Civil Registration System holds data on date of birth, age, gender, and
vital status (daily updated). Furthermore, the registry holds 10-digit
personal identification numbers, which permit database-linkage on
individual patient-level [22].
Study population
First, all patients aged 65 years or older undergoing primary hip
fracture surgery in Denmark from 1st of January 2005 to 31st of
December 2015 and registered in the Danish Multidisciplinary Hip
FractureRegistrywere identified.Only patientswhowere opioid-naïve
at the time of surgery (defined as no opioid dispensing six months
before surgery) and those with at least one opioid dispensing within
eight days to three months after surgery were included in the final
study population. Furthermore, only patients who were alive nine
months after the surgery were included in analyses on long-term
opioid use. Age above 65 years was chosen because the primary data
source for this study was based on the Danish Multidisciplinary Hip
Fracture Registry, which collects clinical data on all hip fracture in
patients above 65 years of age.
Opioid use within three months after surgery and long-
term use
Opioid use was identified from the Danish National Health Service
Prescription Database. Opioid dispensing was collected from six
months before the date of surgery until a year after surgery. Opioid
dispensing in community pharmacies within a seven-day period
before and after the hip fracture surgery date was not included
because data on in-hospital opioid use, directly dispensed by
healthcare providers, are not available from the Danish National
Health Service Prescription Database, and all included patients were
hospitalized within at least part of this period.
The opioids were classified into eight types according to ATC
codes and number of users (Table 1). The opioid types included in the
analyses were: morphine, oxycodone, fentanyl, codeine, tramadol,
buprenorphine, “other opioids” (nicomorphine, oxycodone combined
with naloxone, pethidine, ketobemidone, methadone, and tapenta-
dol), and >1 opioid type. Patients were identified as users of a specific
opioid type based on one ormore redeemedprescription of the specific
opioid types within the period. The category “Other opioids” was
defined based on opioid types with > 1,000 prescriptions redeemed in
total within the first three months after surgery. If patients redeemed
more than one opioid type within three months after surgery, they
were definedwithin the >1 opioid type group; thus, not countedwithin
any specific opioid type group in the analyses.
Long-term opioid use has previously been defined based on
different patterns of repeated prescription redeeming and continua-
tion of opioid therapy for more than 90 days [23, 24]. In the present
study, long-term opioid use up to a year after surgery was defined as
one or more redeemed opioid prescriptions within each of three time
periods the year after hip fracture surgery. The three periods include
3–6 months, 6–9 months, and 9–12 months after hip fracture surgery.
Thus, the overall opioid use (beyond the three months inclusion
criteria) starts within six months after hip fracture surgery and that it
spans for more than three months; although, redemption-free periods
may appear. No information on doses or days’ supply was included in
the definition.
Covariates
The following covariates were assessed from the Danish Multidis-
ciplinary Hip Fracture Registry at the day of surgery: age (in cate-
gories 65–74, 75–84 and ≥85 years), gender, fracture type (femoral
neck or per-/sub-trochanter fracture), and surgery type (osteosyn-
thesis or total/partial hip replacement). Additionally, comorbidity
was identified from the DNPR and summarized using the Charlson
Comorbidity Index (CCI) score, including both primary and sec-
ondary somatic diagnoses from any in- and outpatient contact 10
years preceding the date of hip fracture surgery [25, 26]. In the
absence of good reference for look-back period relevant for opioid
use, 10 years look-back periodwas chosen, since CCI based on DNPR
10 years before submission was found to account for the most pre-
dictive ability of one-year mortality in patients with admission for
Myocardial Infarction in Denmark from 2009 to 2011 [27]. However,
the strength of the association between time of diagnosis and mor-
tality may to some extent be disease dependent [28]. The CCI scores
were classified as ‘no comorbidity’ (CCI score 0), ‘medium comor-
bidity’ (CCI score 1–2) or ‘severe comorbidity’ (CCI score ≥3)
(Table E1.2).
Table : Opioids. The table illustrates the included and analyzed
opioids, ATC codes, administration forms for prescription drugs in
pharmacies, and number of users of each opioid type in total within
eight days to three months after hip fracture surgery in the opioid-
naïve hip fracture population with opioid use after the surgery
(n=,). The number of users of each opioid type indicates a
high amount of users ofmore than one opioid typewithin the period.
ATC: Anatomical Therapeutic Chemical Classification System code,
PO: Per Oral, N: Number of patients.
Opioid ATC Administration n, within first
three month:
Agonists ,
Morphine NAA PO, Rectal ,
Nicomorphine NAA PO 
Oxycodone NAA PO, Rectal ,
Oxycodone +
naloxone
NAA PO ≤
Pethidine NAB PO, Rectal 
Fentanyl NAB Transdermal, Buccal ,
Ketobemidone NAG PO, Rectal 
Codeine NAI PO ,
Methadone NBC PO 
Dual action
agonists:
,
Tramadol NAX PO ,
Tapentadol NAX PO 
Partial agonists: ,
Buprenorphine NAE Transdermal, Buccal ,
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Statistics
Baseline characteristics of the hip fracture cohort were described as
median age and interquartile range (IQR) and proportions (numbers
and percentages) overall and stratified according to opioid types used
within three months after surgery. Additionally, three-, nine-, and
12-month cumulative mortality risk after hip fracture surgery was re-
ported and the three- and nine-month cumulative risk were presented
according to opioid types used within three months after surgery. The
proportion of long-term opioid users conditioned on nine-month
survival was calculated for each opioid type. Uni- and multivariable
logistic regression analyses conditioned on nine-month survival were
performed in order to identify the odds ratios (OR) and adjusted odds
ratios (aOR) for long-term opioid use according to opioid type after hip
fracture surgery compared with morphine as reference group. The
multivariable analyses were adjusted for age, gender, fracture- and
surgery type, and comorbidity level. Corresponding subgroup logistic
regression analyses according to time of surgery (before and after
2010), age, and comorbidity levels were executed. Confidence levels
were set at 95%. Statistical analyses were performed in STATA version
15 (StataCorp, TX, USA).
Results
Patient characteristics
A total of 69,456 patients had primary hip fracture surgery in
Denmark from the 1st of January 2005 to the 31st of December
2015, of whom 27% used opioids within six months prior to
surgery. Additionally, 3% of the hip fracture patients were
opioid-naïve but diedwithin seven days after the surgery and
32% were opioid-naïve but without opioid use within eight
days to three months after the surgery. Thus, 26,790 patients
were included in the study population corresponding to 39%
of the basis population. A study population flowchart is
presented inFigure 1.Medianage for these patients at surgery
was 83 years (IQR 77–88), and 19,094 (71%) of the patients
were women. Baseline characteristics of the patients ac-
cording to use of different opioid types within three months
after hip fracture surgery aswell as number andproportion of
usersof theopioidswithin theperiodarepresented inTable 2,
along with numbers and proportions of patients with use of
each opioid, overall and before and after 2010. This revealed
large differences in prescribing habits in regard to baseline
patient characteristics within the population. Among the
patients included in the study population, 5,535 (21%) died
within eight days to ninemonths after surgery. Consequently,
only 21,255 patients were alive nine month after hip fracture
surgery, and thus, were at-risk of long-term opioid use. This
corresponds to 31% of the basis population.
Mortality according to opioid type
Within the period of eight days to three months after hip
fracture surgery, 3,204 (12%) of the 26,790 included hip
Figure 1: Flowchart. Flowchart on the formation of the study population. Proportions and regression analysis were conditioned on nine-month
survival.
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fracture patients died. The mortality in this period varied
significantly in association with the type of opioid use
(Table 3). Within eight days to nine months after hip frac-
ture surgery, 5,526 (21%) of the 26,790 hip fracture patients
died. The nine-month mortality also varied in association
with the type of opioid use (Table 3). Within eight days to
12 months after hip fracture surgery, 6,274 (23%) of the
26,790 hip fracture patients died in total; 739 (3%) of the
21,255 patients who survived ninemonths after hip fracture
surgery died within 9–12 months.
In the basis population with 69,456 hip fractures in
Denmark from 2005 to 2015, 2,969 (4%) died within seven
days after the surgery, 9,374 (13%) diedwithin eight days to
threemonth, 15,140 (22%) within eight days to ninemonth,
and 17,104 (25%) within eight days to 12 month.
Opioid type and long-term use
Long-term opioid use was observed in 3,213 (15%) of the
21,255 nine-month survivorswhowere opioid-naïve prior to
surgery and redeemed at least one opioid prescription in
the interval from eight days to three months after hip
fracture surgery.
Use of any opioid type within three months after hip
fracture surgery (except the grouped “other opioids”) was
associated with higher odds of long-term opioid use after
hip fracture surgery compared to use of morphine when
looking at the entire study period. Proportion, ORs, and
confidence intervals (CI) for long-term opioid use after hip
fracture surgery, conditioned on nine-month survival,
according to opioid type used within three months after
the surgery are presented in Table 4, both overall and
according to calendar time subpopulations. The propor-
tion of long-term opioid users changed from 18% in the
period before 2010 to 13% in the period after 2010. There
are minimal differences between the crude ORs and the
adjusted ORs. Additionally, ORs and CI for the subgroup
analysis according to age and comorbidity are provided in
Table 5.
Discussion
In this nationwide cohort study 15% of the opioid-naïve
patients who redeemed a prescription opioid in the first
three months after surgery met our definition for long-term
opioid use. Use of oxycodone, fentanyl, codeine, tramadol,
buprenorphine, ormore than one typewithin threemonths
after hip fracture surgery was associated with opioid pre-
scriptions three to 12 months after surgery compared to
morphine. However, baseline characteristics differed ac-
cording to prescriptions and prescription patterns changes
remarkably around 2010.
Interpretation
The present study used person-based linkage between
nationwide registries to explore opioid use among
elderly opioid-naïve patients who underwent hip frac-
ture surgery and subsequently redeemed opioid pre-
scriptions. The present study identified that use of a
variety of opioid types after hip fracture surgery, of
which some are regularly prescribed, were associated
with long-term opioid use compared to morphine.
However, the association may be affected by uncon-
trolled confounding by indication of the opioid pre-
scriptions. The present study surprisingly only found
minimal differences between the crude and the adjusted
ORs for long-term opioid use after hip fracture surgery,
despite differences in baseline characteristics e.g., the
number of users of fentanyl, buprenorphine, codeine,
and other opioids aged ≥85 years were higher compared
to users of morphine, oxycodone, tramadol, and more
than one type, which is the primary finding in this study.
This suggests, these patients have other indications for
opioid use than undergoing a hip fracture surgery. This
expectation strengthens when looking at the mortality
distribution, since the proportions of survivors are lower
among users of fentanyl, buprenorphine, other opioids,
and more than one type. Particularly among users of
fentanyl and buprenorphine, the subgroup analysis
revealed that ORs for long-term opioid use differ between
the lowest and highest age and comorbidity group. As
the study was conditioned on redeemed opioid
Table : Mortality. Three and nine moth mortality in the patients
with use of different opioid types within three and ninemonths after
hip fracture surgery, ranked from the lowest to highest mortality. n:
Number of patients. n=,.
Opioid type
Number
of users
eight days
to three month
eight days
to nine months
n n, % n, %
Oxycodone ,  (%)  (%)
Tramadol ,  (%) , (%)
Codeine   (%)  (%)
Morphine ,  (%)  (%)
> type , , (%) , (%)
Buprenorphine   (%)  (%)
Fentanyl   (%)  (%)
Other opioids   (%)  (%)
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prescriptions after hospital discharge, the mortality in
the basis population was higher than in the study pop-
ulation. Overall, findings indicate that different opioid
types are used for different indications among elderly
previously opioid-naïve hip fracture patients.
Opioid type and long-term use
Themorphine users in the present studywere least likely to
have a long-term opioid use after hip fracture surgery in the
whole study period and especially after 2010. Prescribed
opioid types have changed over time and the Danish na-
tional recommendations are to prescribe morphine as first
choice [6, 29]. It is clear from the results that the choice of
opioids other than morphine after hip fracture surgery is
not random. The use of prescription medication in the
population is affected by changes in society and thera-
peutic indication for prescriptions [29]. Thus, prescribing
behavior appears to be related to other conditions than hip
fracture surgery, and patient awareness of addictive
properties of morphine may also ensure attention to
withdrawal.
Patients with use of oxycodone had 1.8-fold higher
odds of long-term opioid use, than patients with morphine
use in the entire study period. However, in the period
before 2010, the odds for long-term opioid use were no
higher (odds 1.0) than for morphine but increased in the
following period. However, the change in odds according
to calendar time in this study reflects a major change in
prescription of morphine in the two periods. The patients
with oxycodone use had a low CCI before surgery and the
lowest nine-month mortality; thus, the patients seemed
less fragile. However, the odds for long-term opioid use
Table : Long-term opioid use. Proportion, ORs and confidence intervals for long-term opioid use after hip fracture surgery conditioned on
nine-month survival (n=,), according to opioid type used within three months after the surgery. Additionally, the data have been
presented for sub populations for the time period before and after . Numbers and proportions for users of “other opioids” have not been
included in the subpopulations, due to very few cases (n=,). aOR: adjusted odds ratio, CI: Confidence interval, N: Number of patientsOR:
odds ratio, Ref: Reference value.
Proportion with long-term opioid use Univariable analysis Multivariable analysis
Opioid type n, % OR % CI aOR % CI
– (n=,)
Morphine  (%) Ref Ref Ref Ref
Oxycodone  (%) . [.–.] . [.–.]
Fentanyl  (%) . [.–.] . [.–.]
Codeine  (%) . [.–.] . [.–.]
Tramadol  (%) . [.–.] . [.–.]
Buprenorphine  (%) . [.–.] . [.–.]
Other opioids  (%) . [.–.] . [.–.]
> type  (%) . [.–.] . [.–.]
Subpopulation: – (n=,)
Morphine  (%) Ref Ref Ref Ref
Oxycodone  (%) . [.–.] . [.–.]
Fentanyl  (%) . [.–.] . [.–.]
Codeine  (%) . [.–.] . [.–.]
Tramadol  (%) . [.–.] . [.–.]
Buprenorphine  (%) . [.–.] . [.–.]
Other opioids – . [.–.] . [.–.]
> type  (%) . [.–.] . [.–.]
Subpopulation: – (n=,)
Morphine  (%) Ref Ref Ref Ref
Oxycodone  (%) . [.–.] . [.–.]
Fentanyl  (%) . [.–.] . [.–.]
Codeine  (%) . [.–.] . [.–.]
Tramadol  (%) . [.–.] . [.–.]
Buprenorphine  (%) . [.–.] . [.–.]
Other opioids – . [.–.] . [.–.]
> type  (%) . [.–.] . [.–.]
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compared to morphine seemed similar within age and co-
morbidity subgroups. The association with use of oxyco-
done and long-term opioid use is noticeable as it affects a
large proportion, i.e., overall 26% in this study, 31% before
2010 and 21% after.
Tramadol was the most prevalent opioid in this study
used among 34% of the opioid users within three months
after the surgery; however, the number of users decreased
noticeably from 41% in the period before 2010 to 27% in the
period after. This correspond to studies in other patient
populations, who found that the number of tramadol users
in Denmark increased by 70% from 2001 to 2013 but have
decreased by more than 25% from 2016 to 2018 [30, 31].
The present study found that use of fentanyl or
buprenorphine was associated with 4–5 fold higher odds
for long-term opioid use thanmorphine. However, only 4%
of the patients in this studyused buprenorphine or fentanyl
after the surgery and odds for long-term opioid use varied
within the age and comorbidity subgroups. Patients with
use of fentanyl or buprenorphine were mainly aged 85
years or older and suffered a high mortality within three
months (26–45%) and nine months (42–58%) after the
surgery. This is in compliance with the context that indi-
cation for buprenorphine would commonly be chronic
pain, especially in elderly patients [32, 33]. Nevertheless,
this clearly indicates that prescribing behavior appears not
to be related to hip fracture surgery but other circum-
stances which would affect long-term opioid use.
The 3.8 OR of long-term opioid use among users of more
than one opioid type compared to morphine may be
explained by comorbidity and chronic pain among these
patients, which is a strong predictor of long-term opioid use
[13]. In this study, the comorbidity levelwashigher inpatients
with more than one opioid type than other patients, but the
odds did not vary considerably in the subgroup analysis. The
multivariable analysis was adjusted for CCI level, which
summarize the morbidity burden before the surgery. Never-
theless, switching between opioids suggests periods of
insufficient pain management or unacceptable side effects,
possibly related tomorecomplicated conditionsnot related to
the hip fracture surgery.
Methodological considerations and
limitations
Methodological strengths of the study include the
population-based nationwide design with complete access
to healthcare for all citizens and follow-up through patient-
leveled data-linkage. The positive predictive value of the
hip fracture diagnosis is up to 98% [34, 19]. Thus, the risk of
selection bias due to registration failure is low. However,
the analysis was limited to prescriptions redeemed in the
Danish pharmacies as information on medications
dispensed during hospitalization was not accessed in the
present study. Potentially, patients receive a few days’
opioid supply at discharge and the most fragile patients
have longer hospital stays. Opioid prescriptions from
pharmacies were consequently redeemed later among
these patients; thus, initial opioid use may be under-
estimated and the included opioid type was not the first
used after hip fracture surgery which could imply infor-
mation bias. To manage this, all opioids redeemed within
seven days after surgery were excluded. Studies found that
long-term opioid use was associated with opioid dose after
orthopedic surgery [35], or days’ supply on the first
Table : Long-term opioid use in subgroups. ORs and confidence intervals for long-term opioid use after hip fracture surgery in subgroups
according to age and comorbidity, conditioned on nine-month survival (n=,), depending on opioid type used within three months after
the surgery. CI: Confidence interval, N: Number of patients OR: odds ratio, Ref: Reference value.
Univariable analysis Age CCI
–
(n=,)
≥
(n=,)
No comorbidity
(n=,)
Severe comorbidity
(n=,)
Opioid type OR % CI OR % CI OR % CI OR % CI
Morphine Ref Ref Ref Ref Ref Ref Ref Ref
Oxycodone . [.–.] . [.–.] . [.–.] . [.–.]
Fentanyl . [.–.] . [.–.] . [.–.] . [.–.]
Codeine . [.–.] . [.–.] . [.–.] . [.–.]
Tramadol . [.–.] . [.–.] . [.–.] . [.–.]
Buprenorphine . [.–.] . [.–.] . [.–.] . [.–.]
Other opioids . [.–.] . [.–.] . [.–.] . [.–.]
> type . [.–.] . [.–.] . [.–.] . [.–.]
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prescription across multiple pain etiologies, rather than
opioid type [13]. Unfortunately, information on dose and
days’ supply was not available in the present study.
The definition of long-term opioid use, in the present
study (opioids redeemed within all three-month periods
the year after surgery) allow patients to have redemption-
free periods up to almost six months. Thus, new pain
conditions the year following surgery may be observed as
long-term opioid use after hip fracture surgery in some
patients. The analyses were restricted to opioid-naive pa-
tients six months before surgery who redeem opioids
within three months after the surgery. However, since the
present study was based on opioid dispensing data unable
to account for prescription compliance, opioid use may be
overestimated if patients were prescribed opioids without
using them. The Danish National Health Service Prescrip-
tion Database is considered a good predictor of medication
use [21, 36]. However, lacking knowledge on indications
and contraindications for opioid treatment, pain level and
etiology, personal preferences of patients and prescribers’
habits, doses, and benefit from medications, implies that
the results may be confounded by opioid indication. Thus,
comorbidities, e.g., cancer, probably correlate with both
opioid type and long-term use. To obligate this challenge
the multivariate analysis was adjusted for potential con-
founders, including comorbidity. However, given the study
design, casual relations between opioid type and long-term
opioid use after hip fracture surgery could not be identified
due to unknown characteristics such as pain or reasons for
opioid choice. Additionally, the study was confounded by
competing risk of death. The mortality is high in the hip
fracture population and varied within recipients of
different opioid types.
Conclusions
Results from this study demonstrate that use of certain opioid
types after hip fracture surgery including the most commonly
prescribed opioids, tramadol and oxycodone, were associated
with a higher likelihood of long-term opioid use compared to
morphine. However, the proportion of patients initiating a
long-term opioid use decreased after 2010. The findings sug-
gest that some elderly, opioid-naïve, patients have untreated
pain conditions before hip fracture surgery and the hospitali-
zation could be an opportunity to start a relevant pain
treatment. Additionally, the decrease in long-term users em-
phasizes the likelihood of careful and conscientious opioid
prescribingbehavior. Studieswithprospectively collecteddata
on indication for the opioid prescriptions are still warranted.
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